Hosted on MSN3mon
Immedica to buy Marinus Pharmaceuticals for $151m
Global rare disease company Immedica Pharma has agreed to acquire Marinus Pharmaceuticals for an enterprise value of approximately $151m. Marinus is a commercial-stage pharmaceutical company ...
Hosted on MSN11mon
KKR to acquire Swedish pharma firm Immedica
Investment funds managed by KKR (NYSE:KKR) have agreed to acquire Immedica Pharma, a pharmaceutical company headquartered in Stockholm, focused on the commercialization of medicines for rare ...